Larvol Delta - 60-Degrees-Pharmaceuticals-Enrolls-First-Patient-in-Tafenoquine-Expanded-Access-Clinical-Study-for-Persistent-B-microti-Babesiosis

Krintafel (tafenoquine) - 60° Pharma

https://www.globenewswire.com/news-release/2025/01/08/3006241/0/en/60-Degrees-Pharmaceuticals-Enrolls-First-Patient-in-Tafenoquine-Expanded-Access-Clinical-Study-for-Persistent-B-microti-Babesiosis.html

Jan 8, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next